Page last updated: 2024-12-07

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

The full name you provided describes a complex organic molecule with a very specific structure. It is a derivative of **indene** (a bicyclic aromatic hydrocarbon) with multiple substitutions. Let's break down the name to understand its structure:

* **1h-indene-2-carboxylic acid**: This is the base structure. It is an indene molecule with a carboxylic acid (-COOH) group attached at the 2nd position. The 1h indicates the presence of a hydrogen atom at position 1.

* **1-(1,3-benzodioxol-5-yl)**: This indicates a **benzodioxole** group attached at the 1st position of the indene ring. Benzodioxole is a heterocyclic ring containing an oxygen atom and a benzene ring.

* **3-(2-(carboxymethoxy)-4-methoxyphenyl)**: This part describes a phenyl (benzene) ring attached to the 3rd position of the indene ring. This phenyl ring has two substituents:
* **2-(carboxymethoxy)**: A carboxymethoxy group (-COOCH3) at the 2nd position.
* **4-methoxy**: A methoxy group (-OCH3) at the 4th position.

* **2,3-dihydro-5-propoxy-**: This indicates that the double bond between positions 2 and 3 of the indene ring is saturated (with two hydrogen atoms). Additionally, there is a propoxy group (-OCH2CH2CH3) attached at the 5th position of the indene ring.

* **(1s,2r,3s)-**: This describes the stereochemistry of the molecule, indicating the configuration of the chiral centers at positions 1, 2, and 3. s stands for sinister or left-handed configuration.

**Why is it important for research?**

This compound, with its complex structure and multiple functional groups, could potentially possess interesting biological properties. It is likely that researchers are interested in this molecule for the following reasons:

* **Pharmaceutical Potential:** The combination of indene, benzodioxole, and phenyl rings with various functional groups is often seen in pharmacologically active molecules. The compound might have potential as a drug candidate for a variety of diseases.
* **Synthesis and Methodology:** The complex structure of this molecule makes it a challenging synthetic target. Researchers might be interested in developing new synthetic methods to produce this compound and its derivatives.
* **Structure-Activity Relationships:** Understanding the relationship between the molecular structure and biological activity of this molecule is crucial for designing new and improved drug candidates.

**To determine the exact importance of this specific compound in research, it is necessary to consult relevant scientific literature or databases. The research focus could vary depending on the specific context.**

1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-: an ET(A) and ET(B) endothelin receptor antagonist; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID108002
CHEMBL ID8823
SCHEMBL ID1028671
MeSH IDM0578191

Synonyms (30)

Synonym
(1s,2r,3s)-1-benzo[1,3]dioxol-5-yl-3-(2-carboxymethoxy-4-methoxy-phenyl)-5-propoxy-indan-2-carboxylic acid
1-benzo[d][1,3]dioxol-5-ylmethyl-3-(2-carboxymethoxy-4-methoxyphenyl)-5-propoxy-(1r,3s)-2,3-dihydro-1h-2-indenecarboxylic acid
bdbm50041617
sb 209670
sb-209670
3-(2-(carboxymethoxy)-4-methoxyphenyl)-1-(3,4-(methylenedioxy)phenyl)-5-(prop-1-yloxy)indan-2-carboxylic acid
1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2-(carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s-(1alpha,2beta,3alpha))-
1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2-(carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-
PDSP2_001717 ,
sb209670
1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-
CHEMBL8823 ,
(1s,2r,3s)-1-(1,3-benzodioxol-5-yl)-3-[2-(carboxymethyloxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1h-indene-2-carboxylic acid
unii-0i32bcl40z
0i32bcl40z ,
157659-79-5
skb-209670
skb 209670
gtpl3528
SCHEMBL1028671
(1s,2r,3s)-1-(1,3-benzodioxol-5-yl)-3-[2-(carboxymethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1h-indene-2-carboxylic acid
(+) (1s, 2r, 3s)-3-(2-carboxymethoxy-4-methoxyphenyl)-1-(3,4-methylenedioxyphenyl)-5-(prop-1-yloxy)indane-2-carboxylic acid
(+)(1s,2r,3s)-3-(2-carboxymethoxy-4-methoxyphenyl)-1-(3,4-methylenedioxyphenyl)-5-(prop-1-yloxy)indane-2-carboxylic acid
UUAVCCWBNUITBB-UPRLRBBYSA-N ,
DTXSID00935762
1-(2h-1,3-benzodioxol-5-yl)-3-[2-(carboxymethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1h-indene-2-carboxylic acid
Q27088700
1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-[2-(carboxymethoxy)-4-methoxyphenyl]-2,3-dihydro-5-propoxy-, (1s,2r,3s)-
(1s,2r,3s)-1-(1,3-benzodioxol-5-yl)-3-[2-(carboxymethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1h-indene-2-carboxylic acid.
AKOS040753947

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Adverse effects, especially hypotension or decreased blood pressure, were more common in the SB 209670 group."( Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.
Bashore, TM; Davidson, CJ; Freed, MI; Holcslaw, T; Miller, D; Rudnick, MR; Schwab, SJ; Shusterman, N; Szerlip, H; Thames, MD; Wang, A, 2000
)
0.31

Pharmacokinetics

ExcerptReferenceRelevance
" The half-life was approximately 4 to 5 hours."( Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: effects on the regulation of renal vascular tone.
Freed, MI; Harris, RZ; Ilson, BE; Jorkasky, DK; Thompson, KA; Wilson, DE, 1999
)
0.3

Bioavailability

ExcerptReferenceRelevance
" The compound has 70% oral bioavailability in rats."( 2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
Bal, R; Boyd, SA; Chiou, WJ; Dixon, DB; Hernandez, L; Jae, HS; Kester, JA; Mantei, RA; Marsh, KC; Novosad, EI; Opgenorth, TJ; Sorensen, BK; Tasker, AS; von Geldern, TW; Winn, M; Wu-Wong, JR, 1996
)
0.29

Dosage Studied

ExcerptRelevanceReference
" An identical dosage regimen of BQ-123 did not exhibit significant vasculoprotection (neointima:media ratio of 128% vehicle control)."( Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670.
Douglas, SA; Elliott, JD; Louden, C; Ohlstein, EH; Vickery-Clark, LM, 1995
)
0.29
" PD, SB, and BQ produced parallel concentration-dependent rightward shifts in the S6c dose-response curve in the kidney."( PD 142893, SB 209670, and BQ 788 selectively antagonize vascular endothelial versus vascular smooth muscle ET(B)-receptor activity in the rat.
Cheng, XM; Haleen, SJ; Keiser, JA; Schroeder, RL, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Endothelin receptor type BHomo sapiens (human)Ki0.01580.00010.05430.3710AID66360; AID66689; AID66691
Endothelin-1 receptorHomo sapiens (human)Ki0.00040.00000.430010.0000AID68296; AID68485; AID68488
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (109)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIEndothelin receptor type BHomo sapiens (human)
neural crest cell migrationEndothelin receptor type BHomo sapiens (human)
positive regulation of protein phosphorylationEndothelin receptor type BHomo sapiens (human)
renin secretion into blood streamEndothelin receptor type BHomo sapiens (human)
regulation of heart rateEndothelin receptor type BHomo sapiens (human)
regulation of pHEndothelin receptor type BHomo sapiens (human)
cell surface receptor signaling pathwayEndothelin receptor type BHomo sapiens (human)
negative regulation of adenylate cyclase activityEndothelin receptor type BHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayEndothelin receptor type BHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationEndothelin receptor type BHomo sapiens (human)
nervous system developmentEndothelin receptor type BHomo sapiens (human)
peripheral nervous system developmentEndothelin receptor type BHomo sapiens (human)
posterior midgut developmentEndothelin receptor type BHomo sapiens (human)
positive regulation of cell population proliferationEndothelin receptor type BHomo sapiens (human)
gene expressionEndothelin receptor type BHomo sapiens (human)
negative regulation of neuron maturationEndothelin receptor type BHomo sapiens (human)
response to organic cyclic compoundEndothelin receptor type BHomo sapiens (human)
vein smooth muscle contractionEndothelin receptor type BHomo sapiens (human)
calcium-mediated signalingEndothelin receptor type BHomo sapiens (human)
cGMP-mediated signalingEndothelin receptor type BHomo sapiens (human)
heparin metabolic processEndothelin receptor type BHomo sapiens (human)
melanocyte differentiationEndothelin receptor type BHomo sapiens (human)
regulation of fever generationEndothelin receptor type BHomo sapiens (human)
aldosterone metabolic processEndothelin receptor type BHomo sapiens (human)
enteric smooth muscle cell differentiationEndothelin receptor type BHomo sapiens (human)
positive regulation of urine volumeEndothelin receptor type BHomo sapiens (human)
renal sodium excretionEndothelin receptor type BHomo sapiens (human)
epithelial fluid transportEndothelin receptor type BHomo sapiens (human)
vasoconstrictionEndothelin receptor type BHomo sapiens (human)
vasodilationEndothelin receptor type BHomo sapiens (human)
negative regulation of apoptotic processEndothelin receptor type BHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionEndothelin receptor type BHomo sapiens (human)
macrophage chemotaxisEndothelin receptor type BHomo sapiens (human)
response to painEndothelin receptor type BHomo sapiens (human)
enteric nervous system developmentEndothelin receptor type BHomo sapiens (human)
regulation of epithelial cell proliferationEndothelin receptor type BHomo sapiens (human)
negative regulation of protein metabolic processEndothelin receptor type BHomo sapiens (human)
canonical Wnt signaling pathwayEndothelin receptor type BHomo sapiens (human)
positive regulation of penile erectionEndothelin receptor type BHomo sapiens (human)
establishment of endothelial barrierEndothelin receptor type BHomo sapiens (human)
renal sodium ion absorptionEndothelin receptor type BHomo sapiens (human)
calcium ion transmembrane transportEndothelin receptor type BHomo sapiens (human)
cellular response to lipopolysaccharideEndothelin receptor type BHomo sapiens (human)
protein transmembrane transportEndothelin receptor type BHomo sapiens (human)
podocyte differentiationEndothelin receptor type BHomo sapiens (human)
endothelin receptor signaling pathwayEndothelin receptor type BHomo sapiens (human)
renal albumin absorptionEndothelin receptor type BHomo sapiens (human)
neuroblast migrationEndothelin receptor type BHomo sapiens (human)
chordate pharynx developmentEndothelin receptor type BHomo sapiens (human)
response to sodium phosphateEndothelin receptor type BHomo sapiens (human)
response to endothelinEndothelin receptor type BHomo sapiens (human)
developmental pigmentationEndothelin receptor type BHomo sapiens (human)
mitotic cell cycleEndothelin-1 receptorHomo sapiens (human)
branching involved in blood vessel morphogenesisEndothelin-1 receptorHomo sapiens (human)
response to hypoxiaEndothelin-1 receptorHomo sapiens (human)
in utero embryonic developmentEndothelin-1 receptorHomo sapiens (human)
blood vessel remodelingEndothelin-1 receptorHomo sapiens (human)
response to amphetamineEndothelin-1 receptorHomo sapiens (human)
regulation of heart rateEndothelin-1 receptorHomo sapiens (human)
glomerular filtrationEndothelin-1 receptorHomo sapiens (human)
cardiac chamber formationEndothelin-1 receptorHomo sapiens (human)
left ventricular cardiac muscle tissue morphogenesisEndothelin-1 receptorHomo sapiens (human)
atrial cardiac muscle tissue developmentEndothelin-1 receptorHomo sapiens (human)
cardiac neural crest cell migration involved in outflow tract morphogenesisEndothelin-1 receptorHomo sapiens (human)
noradrenergic neuron differentiationEndothelin-1 receptorHomo sapiens (human)
intracellular calcium ion homeostasisEndothelin-1 receptorHomo sapiens (human)
smooth muscle contractionEndothelin-1 receptorHomo sapiens (human)
mitochondrion organizationEndothelin-1 receptorHomo sapiens (human)
signal transductionEndothelin-1 receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayEndothelin-1 receptorHomo sapiens (human)
activation of adenylate cyclase activityEndothelin-1 receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayEndothelin-1 receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayEndothelin-1 receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationEndothelin-1 receptorHomo sapiens (human)
respiratory gaseous exchange by respiratory systemEndothelin-1 receptorHomo sapiens (human)
regulation of blood pressureEndothelin-1 receptorHomo sapiens (human)
cell population proliferationEndothelin-1 receptorHomo sapiens (human)
response to woundingEndothelin-1 receptorHomo sapiens (human)
gene expressionEndothelin-1 receptorHomo sapiens (human)
protein kinase A signalingEndothelin-1 receptorHomo sapiens (human)
regulation of glucose transmembrane transportEndothelin-1 receptorHomo sapiens (human)
neural crest cell fate commitmentEndothelin-1 receptorHomo sapiens (human)
artery smooth muscle contractionEndothelin-1 receptorHomo sapiens (human)
neuron remodelingEndothelin-1 receptorHomo sapiens (human)
heparin metabolic processEndothelin-1 receptorHomo sapiens (human)
thyroid gland developmentEndothelin-1 receptorHomo sapiens (human)
cellular response to oxidative stressEndothelin-1 receptorHomo sapiens (human)
embryonic heart tube developmentEndothelin-1 receptorHomo sapiens (human)
aorta developmentEndothelin-1 receptorHomo sapiens (human)
vasoconstrictionEndothelin-1 receptorHomo sapiens (human)
norepinephrine metabolic processEndothelin-1 receptorHomo sapiens (human)
middle ear morphogenesisEndothelin-1 receptorHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionEndothelin-1 receptorHomo sapiens (human)
cellular response to human chorionic gonadotropin stimulusEndothelin-1 receptorHomo sapiens (human)
enteric nervous system developmentEndothelin-1 receptorHomo sapiens (human)
sympathetic nervous system developmentEndothelin-1 receptorHomo sapiens (human)
axon extensionEndothelin-1 receptorHomo sapiens (human)
embryonic skeletal system developmentEndothelin-1 receptorHomo sapiens (human)
neuromuscular processEndothelin-1 receptorHomo sapiens (human)
sodium ion homeostasisEndothelin-1 receptorHomo sapiens (human)
canonical Wnt signaling pathwayEndothelin-1 receptorHomo sapiens (human)
face developmentEndothelin-1 receptorHomo sapiens (human)
axonogenesis involved in innervationEndothelin-1 receptorHomo sapiens (human)
establishment of endothelial barrierEndothelin-1 receptorHomo sapiens (human)
pharyngeal arch artery morphogenesisEndothelin-1 receptorHomo sapiens (human)
renal sodium ion absorptionEndothelin-1 receptorHomo sapiens (human)
calcium ion transmembrane transportEndothelin-1 receptorHomo sapiens (human)
cellular response to follicle-stimulating hormone stimulusEndothelin-1 receptorHomo sapiens (human)
cellular response to luteinizing hormone stimulusEndothelin-1 receptorHomo sapiens (human)
protein transmembrane transportEndothelin-1 receptorHomo sapiens (human)
glomerular endothelium developmentEndothelin-1 receptorHomo sapiens (human)
podocyte differentiationEndothelin-1 receptorHomo sapiens (human)
endothelin receptor signaling pathway involved in heart processEndothelin-1 receptorHomo sapiens (human)
renal albumin absorptionEndothelin-1 receptorHomo sapiens (human)
vascular associated smooth muscle cell developmentEndothelin-1 receptorHomo sapiens (human)
mesenchymal cell apoptotic processEndothelin-1 receptorHomo sapiens (human)
sympathetic neuron axon guidanceEndothelin-1 receptorHomo sapiens (human)
semaphorin-plexin signaling pathway involved in axon guidanceEndothelin-1 receptorHomo sapiens (human)
podocyte apoptotic processEndothelin-1 receptorHomo sapiens (human)
meiotic cell cycle process involved in oocyte maturationEndothelin-1 receptorHomo sapiens (human)
cranial skeletal system developmentEndothelin-1 receptorHomo sapiens (human)
response to acetylcholineEndothelin-1 receptorHomo sapiens (human)
regulation of protein localization to cell leading edgeEndothelin-1 receptorHomo sapiens (human)
positive regulation of cation channel activityEndothelin-1 receptorHomo sapiens (human)
endothelin receptor signaling pathwayEndothelin-1 receptorHomo sapiens (human)
developmental pigmentationEndothelin-1 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
endothelin receptor activityEndothelin receptor type BHomo sapiens (human)
protein bindingEndothelin receptor type BHomo sapiens (human)
peptide hormone bindingEndothelin receptor type BHomo sapiens (human)
type 1 angiotensin receptor bindingEndothelin receptor type BHomo sapiens (human)
phosphatidylinositol phospholipase C activityEndothelin-1 receptorHomo sapiens (human)
endothelin receptor activityEndothelin-1 receptorHomo sapiens (human)
protein bindingEndothelin-1 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneEndothelin receptor type BHomo sapiens (human)
nuclear membraneEndothelin receptor type BHomo sapiens (human)
plasma membraneEndothelin receptor type BHomo sapiens (human)
plasma membraneEndothelin-1 receptorHomo sapiens (human)
plasma membraneEndothelin-1 receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID45775Evaluated for inhibition of ET-1 induced Calcium channel [Ca+2]i in CHO-K1 cells transfected with the rat ETA-expression plasmid DNA at 10 nM2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Carbazolothiophene-2-carboxylic acid derivatives as endothelin receptor antagonists.
AID66689Inhibition of [125I]ET1 binding to cloned human ET-B receptor1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
AID67024Binding constant for ET-1 induced isolated rat aortal strip contraction1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
AID66360Ability to displace endothelin ([125I]ET1) from human Endothelin B receptor1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.
AID68296Ability to displace endothelin ([125I]ET1) from human Endothelin A receptor1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.
AID66691Inhibitory activity against human Endothelin B receptor in chinese hamster ovary cells1996Journal of medicinal chemistry, Mar-01, Volume: 39, Issue:5
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
AID225829In vivo prevention of ET-1-induced sudden death in rats by pretreatment with endothelin receptor antagonist at a dose of 30 mg/kg p.o.; nd = not determined1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.
AID225828In vivo prevention of ET-1-induced sudden death in rats by pretreatment with endothelin receptor antagonist at a dose of 10 mg/kg p.o.; nd = not determined1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.
AID68485Inhibition of [125I]ET1 binding to cloned human ET-A receptor1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
AID66854Ratio of endothelin A receptor and endothelin B receptor.1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.
AID68488Inhibitory activity against human Endothelin A receptor in chinese hamster ovary cells1996Journal of medicinal chemistry, Mar-01, Volume: 39, Issue:5
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
AID225827In vivo prevention of ET-1-induced sudden death in rats by pretreatment with endothelin receptor antagonist at a dose of 100 mg/kg p.o.; nd = not determined1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.
AID224984Ability to protect rats from ET-1 induced sudden death in rats after peroral administration1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.
AID166824Functional vascular ET-1 antagonism was determined in rabbit aorta rings with intact endothelium1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.
AID1345853Rat ETB receptor (Endothelin receptors)1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
AID1345868Rat ETA receptor (Endothelin receptors)1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (120)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's72 (60.00)18.2507
2000's47 (39.17)29.6817
2010's1 (0.83)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.24 (24.57)
Research Supply Index4.84 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (2.44%)5.53%
Reviews3 (2.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other117 (95.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]